Sarah Eichenberger

Title: The Innovative Contributions of Sarah Eichenberger

Introduction

Sarah Eichenberger is a notable inventor based in Wallisellen, Switzerland. She has made significant strides in the field of cannabinoid research, particularly focusing on the conversion of THC, CBD, and their derivatives to Cannabinol. Her work has implications for the pharmaceutical industry and the development of cannabinoid-based therapies.

Latest Patents

Eichenberger holds a patent for a method that aromatizes an alicyclic region of a cannabinoid. This method is particularly relevant for enantiopure, scalemic, and racemic forms of cannabinoids. The patent details the process of aromatizing the cyclohexene group in various cannabinoid compounds, including Δ-THC-C, Δ-THCA-CA, Δ-THCV-C, and Δ-THCVA-CA. The method involves the addition of an oxidizing agent to the cannabinoid, utilizing sulfur as the oxidizing agent.

Career Highlights

Throughout her career, Eichenberger has worked with esteemed institutions such as ETH Zurich and Swiss Cannapharmaceutical SA. Her contributions to cannabinoid research have positioned her as a key figure in the field, and her innovative methods are paving the way for future advancements.

Collaborations

Eichenberger has collaborated with notable colleagues, including Patrick Pfaff and Erick Moran Carreira. These partnerships have enhanced her research and contributed to the development of her patented methods.

Conclusion

Sarah Eichenberger's work in cannabinoid research exemplifies the innovative spirit of modern inventors. Her patent and collaborations highlight her commitment to advancing the field and improving therapeutic options for patients.